title: Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma.
abstract: OBJECTIVE
  Adverse drug reactions (ADRs) are a well-known cause of hospital admission. Nevertheless a quantitative estimate of the preventability of and physicians' awareness of these reactions is lacking.
  
  
  METHODS
  Using intensive bedside and computer-assisted drug surveillance methods a 13-month prospective pharmacoepidemiological survey was carried out on patients admitted to two medical wards of the Erlangen-Nuremberg University Hospital in Erlangen, Germany. This study aimed to define the incidence of preventable and unavoidable ADRs. In addition we investigated the awareness of the physicians to ADRs at the time of admission and the rate of contraindicated pre-admission prescriptions.
  
  
  RESULTS
  In 78 (8.5%) of 915 (10.9%) admissions a total of 102 (42 preventable) community-acquired ADRs were detected on admission. In 45 (3.8%) of the admissions ADRs led directly to hospitalisation. 56.9% of the ADRs were not recognised by the attending physician on admission. Marked correlation was found between the awareness of ADRs and their probability and severity scores (r = 0.85 and r = 0.94, respectively; p < 0.05). The most frequently detected ADRs were due to direct toxicity and secondary pharmacological effects. Idiosyncratic reactions were often missed and 18.6% of all drugs prescribed prior to admission were contraindicated. Leading the list were diuretics, analgesics/NSAIDs and antipsychotics/sedatives.
  
  
  CONCLUSIONS
  Awareness of existing ADRs on hospital admission and appropriate prescribing prior to hospital admission require attention. Early detection of ADRs on hospital admission can be achieved by the use of computer support systems. Many ADRs could be prevented by adhering to indications and contraindications.
authors.affiliation: Department of Internal Medicine I, University of Erlangen-Nuremberg, Erlangen, Germany. harald.dormann@med1.imed.uni-erlangen.de
authors.forename: Harald
authors.initials: H
authors.lastname: Dormann
authors.forename: Manfred
authors.initials: M
authors.lastname: Criegee-Rieck
authors.forename: Antje
authors.initials: A
authors.lastname: Neubert
authors.forename: Tobias
authors.initials: T
authors.lastname: Egger
authors.forename: Arnim
authors.initials: A
authors.lastname: Geise
authors.forename: Sabine
authors.initials: S
authors.lastname: Krebs
authors.forename: Thomas
authors.initials: T
authors.lastname: Schneider
authors.forename: Micha
authors.initials: M
authors.lastname: Levy
authors.forename: Eckhart
authors.initials: E
authors.lastname: Hahn
authors.forename: Kay
authors.initials: K
authors.lastname: Brune
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D004342:Drug Hypersensitivity / Q000453:epidemiology / Q000517:prevention & control; D004347:Drug Interactions; D016903:Drug Monitoring; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005858:Germany; D006760:Hospitalization / Q000706:statistics & numerical data*; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies